top of page
A framework to support new product introduction in national health systems
Resource Library


CAB Case Studies from Ethiopia
These Community Advisory Board (CAB) case studies capture highlights of what CAB members considered to be some of the most impactful...
Jan 3, 2024
Â
Â


Optimal CAB Case Study: Pediatric Dolutegravir
This case study, developed by the Optimal CAB in Malawi with support from CHAI, outlines the efforts undertaken by Malawi CAB members to...
May 31, 2023
Â
Â


Community Statements on DRV/r Use in 2L
In December 2022, 40+ community groups and an additional 45+ individuals released a community position statement calling on the global...
Feb 27, 2023
Â
Â


CAB Case Studies from Tanzania
These FASTER and AIDS Free Community Advisory Board (CAB) case studies capture pediatric and adolescent activities to highlight what CAB...
Feb 16, 2023
Â
Â


CAB Case Studies from Zambia
These FASTER and AIDS Free Community Advisory Board (CAB) case studies capture pediatric and adolescent activities to highlight what CAB...
Feb 16, 2023
Â
Â


CAB Case Studies from Nigeria
These FASTER and AIDS Free Community Advisory Board (CAB) case studies capture pediatric and adolescent activities to highlight what CAB...
Feb 16, 2023
Â
Â


CAB Case Studies from Uganda
These FASTER and AIDS Free Community Advisory Board (CAB) case studies capture pediatric and adolescent activities to highlight what CAB...
Feb 16, 2023
Â
Â


Prevention Product Preference Brief
New products, including long-acting formulations, will be critical to achieve HIV treatment and prevention targets and close gaps among...
Oct 18, 2022
Â
Â


CAB-LA Community Meeting Overview
A Community Forum: Supporting Affordable Access to Long-Acting Injectable Cabotegravir (CAB-LA) took place in Kampala, Uganda from June...
Oct 18, 2022
Â
Â


AHD Community Advocacy Video
This video was developed by Community Advisory Board (CAB) members, and is intended to increase awareness and utilization of services for...
Sep 12, 2022
Â
Â


Pediatric DTG Advocacy Video for Communities (English and French)
This advocacy video provides a brief overview of pDTG to encourage demand generation for the product. The video is available at the...
Sep 12, 2022
Â
Â


Optimal CAB Case Study: Enabling and Ensuring Equitable HIV Treatment for Women
This case study, developed by the Optimal CAB with support from CHAI, outlines the mobilization of community members in response to the...
Jul 31, 2022
Â
Â


Case Study: Community-Developed HIV Care and Treatment Literacy Improves Uptake of Optimal Medicines
This case study, developed by the Optimal CAB with support from CHAI, outlines the tremendous work done by community members developing...
Jul 31, 2022
Â
Â


AHD Social Media Campaign
These resources, developed by Community Advisory Board (CAB) members, are intended to increase awareness and utilization of services for...
Jun 16, 2022
Â
Â


The Community's Corner: Optimal CAB Newsletter
This newsletter shares learnings and highlights of the CHAI-Unitaid Optimal Community Advisory Board (CAB) and its members. The...
Oct 18, 2021
Â
Â


Community Resources for Pediatric DTG Scale-Up
Optimal and FASTER CAB members, with technical support from CHAI, developed a multi-media package of treatment literacy and advocacy...
Jul 9, 2021
Â
Â


AfroCAB / CHAI Community Consultation and Webinar Series
In response to the growing uncertainty and challenges as a result of the COVID-19 pandemic, AfroCAB and CHAI introduced the AfroCAB/CHAI...
Aug 1, 2020
Â
Â


Communique of the Kigali Community Meeting on Dolutegravir and Weight Gain
In this meeting of people living with HIV, participants deliberated on the emerging data on DTG-associated weight gain and hyperglycemia....
Mar 1, 2020
Â
Â


Case Study: Partnering with Communities of PLHIV Accelerates Access to Optimal Treatment
This case study outlines the process of creating the Optimal ARV Community Advisory Board (CAB) and the impact the CAB has had on...
Dec 1, 2018
Â
Â


Optimal ARV Community Advisory Board Terms of Reference
Developed by CHAI and Unitaid, these terms of reference outline the role, responsibilities, and governance of the Optimal ARV Community...
Nov 1, 2017
Â
Â
bottom of page